Trained immunity and the regulation of anti-fungal defense
训练有素的免疫力和抗真菌防御的调节
基本信息
- 批准号:10557883
- 负责人:
- 金额:$ 63.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-01 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAddressAffectAlveolar MacrophagesAntifungal AgentsAspergillosisAspergillus fumigatusCellsCessation of lifeClinicalCritical PathwaysCryptococcosisCryptococcus gattiiCryptococcus neoformansDataDefectDevelopmentDrug resistanceEmbryoEpigenetic ProcessExhibitsExposure toFungal VaccinesFutureGene TargetingGenetic TranscriptionHealthHost Defense MechanismIFNAR1 geneImmuneImmunityImmunizationImmunocompromised HostImmunosuppressionIn VitroInfectionInfection ControlInflammationInterferonsInterventionLifeLiteratureLungLung infectionsMacrophageMediatorMedicalMoldsMusMycosesNatural ImmunityOpportunistic InfectionsPathway interactionsPatient-Focused OutcomesPatientsPhagocytesPharmaceutical PreparationsPopulationPredispositionPublishingRecording of previous eventsRegulationRoleSTAT1 geneShapesSiblingsSignal TransductionSourceStimulusSystems BiologyT-LymphocyteTestingTherapeuticTissuesTrainingVaccinescross immunitycytokinefungusimmunogenicimprovedin vivoinsightloss of functionlung pathogenmonocytemortalityneutrophilnovelpathogenpathogenic fungusresponsevaccine candidate
项目摘要
Abstract:
Although often overlooked as a significant health problem, pulmonary infections with fungal pathogens present
a clinical problem of growing concern. Aspergillus fumigatus (Af) and Cryptococcus neoformans (Cn) are two
clinically important fungal pathogens that affect immunosuppressed patients worldwide. Both infections are
difficult to treat and are associated with high mortality rates. A better understanding of immune mechanisms of
host defense against fungi hold the promise of providing the basis for the future development of novel, immune
based interventions to improve patient outcomes. Pulmonary macrophages are critical, front-line mediators of
host protection against fungi and other pulmonary pathogens. Despite the well-defined role of lung macrophages
as crucial initiators of immunity to diverse sets of pathogens, our understanding of how previous infection history
shapes subsequent macrophage responses to fungal infection in the lung remain poorly defined. Moreover, an
emerging body of literature has now revealed that macrophage populations in the lung are more heterogeneous
than originally appreciated and can undergo innate training; an enhanced response to diverse secondary
challenges. It is now also understood that alveolar macrophages present in the lung can originate from embryonic
precursors (tissue-derived alveolar macrophages-TD-AMs) or from blood monocytes (monocyte-derived alveolar
macrophages-Mo-AMs). Whether TD-AM and Mo-AM are equally capable of undergoing innate training is
currently unclear. It is also unknown whether innate training is a conserved response to any infectious stimuli or
regulated by specific pathways. In preliminary studies, we uncovered that priming with an immunogenic strain of
Cn (HK-fbp1) could confer heterologous protection against infection with Af even in the context of drug-induced
immunosuppression and in a T cell-independent manner. Preliminary data gathered, suggest that neutrophils
and STAT1-dependent signals are important regulators of antifungal monocytes and their differentiation into
monocyte-derived cells. Based on our aggregate observations, the central hypothesis of this project is that:
CCR2+mo are critical mediators of antifungal immunity and can be instructed by HK-fbp1 into trained mo-AM via
the coordinated actions of neutrophils and an interferon (IFN) cascade. We will address two related but
independent aims: Aim 1: Investigate the impact of HK-fbp1 immunization to pulmonary innate cell priming and
training to promote antifungal immunity; Aim 2: Decipher the contributions of neutrophils in the regulation of
antifungal trained immunity.
摘要:
虽然经常被忽视是一个重大的健康问题,但肺部感染的真菌病原体仍然存在。
一个日益令人担忧的临床问题。烟曲霉(Af)和新生隐球菌(Cn)是两种
影响世界各地免疫抑制患者的临床重要真菌病原体。这两种感染都是
难以治疗,并与高死亡率有关。更好地了解脑炎的免疫机制
寄主对真菌的防御有望为未来新型、免疫
以改善患者预后为基础的干预措施。肺巨噬细胞是关键的、前线的介质
宿主对真菌和其他肺部病原体的保护。尽管肺巨噬细胞的作用是明确的
作为对多种病原体免疫的关键启动者,我们对以前的感染史的理解
肺部真菌感染后巨噬细胞反应的形态仍不明确。此外,一个
新出现的文献表明,肺中的巨噬细胞群更加异质性。
比最初意识到的更好,并可以接受先天训练;对不同的次要因素的增强反应
挑战。现在还了解到,肺中存在的肺泡巨噬细胞可以起源于胚胎。
前体(组织来源的肺泡巨噬细胞-TD-AM)或来自血液的单核细胞(单核细胞来源的肺泡
巨噬细胞-钼-AM)。TD-AM和MO-AM是否同样有能力进行先天训练
目前尚不清楚。也不知道先天训练是对任何感染性刺激的保守反应还是
由特定的途径调节。在初步研究中,我们发现用一种免疫原性菌株
CN(HK-FBP1)即使在药物诱导的情况下也能提供对Af感染的异种保护作用
免疫抑制和非T细胞依赖的方式。收集的初步数据表明,中性粒细胞
和STAT1依赖的信号是抗真菌单核细胞及其分化为
单核细胞来源的细胞。根据我们的综合观察,该项目的中心假设是:
CCR2+mo是抗真菌免疫的关键介质,可由HK-FBP1通过
中性粒细胞和干扰素(干扰素)的协同作用。我们将讨论两个相关的但
独立目标:目标1:研究HK-FBP1免疫对肺固有细胞启动和免疫的影响
训练以促进抗真菌免疫;目标2:破译中性粒细胞在调节
抗真菌训练的免疫力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Amariliz Rivera其他文献
Amariliz Rivera的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Amariliz Rivera', 18)}}的其他基金
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
疫苗预防艾滋病相关隐球菌感染的机制
- 批准号:
10793773 - 财政年份:2019
- 资助金额:
$ 63.08万 - 项目类别:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
疫苗预防艾滋病相关隐球菌感染的机制
- 批准号:
10574561 - 财政年份:2019
- 资助金额:
$ 63.08万 - 项目类别:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
疫苗预防艾滋病相关隐球菌感染的机制
- 批准号:
10542652 - 财政年份:2019
- 资助金额:
$ 63.08万 - 项目类别:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
疫苗预防艾滋病相关隐球菌感染的机制
- 批准号:
10097978 - 财政年份:2019
- 资助金额:
$ 63.08万 - 项目类别:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
疫苗预防艾滋病相关隐球菌感染的机制
- 批准号:
10335166 - 财政年份:2019
- 资助金额:
$ 63.08万 - 项目类别:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
疫苗预防艾滋病相关隐球菌感染的机制
- 批准号:
9886185 - 财政年份:2019
- 资助金额:
$ 63.08万 - 项目类别:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
疫苗预防艾滋病相关隐球菌感染的机制
- 批准号:
10274411 - 财政年份:2019
- 资助金额:
$ 63.08万 - 项目类别:
Regulation of antifungal immunity by monocyte-derived dendritic cells
单核细胞来源的树突状细胞抗真菌免疫的调节
- 批准号:
9263884 - 财政年份:2015
- 资助金额:
$ 63.08万 - 项目类别:
Role of CCR2+ monocytes and Mo-DCs in defense against IA and GVHD development
CCR2 单核细胞和 Mo-DC 在防御 IA 和 GVHD 发展中的作用
- 批准号:
8701013 - 财政年份:2013
- 资助金额:
$ 63.08万 - 项目类别:
Role of CCR2+ monocytes and Mo-DCs in defense against IA and GVHD development
CCR2 单核细胞和 Mo-DC 在防御 IA 和 GVHD 发展中的作用
- 批准号:
8637016 - 财政年份:2013
- 资助金额:
$ 63.08万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 63.08万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 63.08万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 63.08万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 63.08万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 63.08万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 63.08万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 63.08万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 63.08万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 63.08万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 63.08万 - 项目类别:
Research Grant